408 filings
Page 2 of 21
424B3
2fanrzbd7110slkcm
1 Aug 23
Prospectus supplement
4:47pm
424B3
sh70ecdzgpqs1ykw a9h
12 Jul 23
Prospectus supplement
12:00am
EFFECT
wkiha40leuv
12 Jul 23
Notice of effectiveness
12:00am
UPLOAD
onpjhz z4073ot0zoigv
10 Jul 23
Letter from SEC
12:00am
CORRESP
sqcgisjrmhs
10 Jul 23
Correspondence with SEC
12:00am
8-K
axc 13wjh5wv
29 Jun 23
Departure of Directors or Certain Officers
5:19pm
8-K
mdoz2owra9ms0 re4
9 Jun 23
Other Events
9:23am
D/A
yut04
31 May 23
$81.00 mm in equity / options / securities to be acquired, sold $81.00 mm, 16 investors
4:13pm
8-K
5652pw7xr
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
lszob 4a1og
15 May 23
Alimera Sciences Reports First Quarter 2023 Results
9:05am
S-8
jog1tr9t3cp4pb0
28 Apr 23
Registration of securities for employees
4:58pm
D
0ilvpsavo7f7dxwafor
7 Apr 23
$27.00 mm in equity / options / securities to be acquired, sold $12.00 mm, 4 investors
5:12pm
8-K
w1e7dbzyrix b42mf7b
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
DEFA14A
bxio7
27 Mar 23
Additional proxy soliciting materials
10:12am